By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Heptares 

1-3 Burtonhole Lane, Mill Hill

London    NW7 1AD  United Kingdom
Phone: 44-0-20-8906-7100 Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Discovery





Company News
Sosei Subsidiary Heptares Announces Positive Outcome Of Phase 1a Study With First-Ever Selective Muscarinic M1 Receptor Agonist For Improving Cognition In Patients With Alzheimer's Disease 6/17/2015 11:16:21 AM
Heptares Announces Positive Outcome Of Phase 1A Study With First-Ever Selective Muscarinic M1 Receptor Agonist For Improving Cognition In Patients With Alzheimer's Disease 6/17/2015 6:20:06 AM
Sosei Snags UK Biotech Firm Heptares for $400 Million 2/23/2015 5:54:15 AM
Heptares Scientists To Receive The Malcolm Campbell Memorial Prize For 2015 In Recognition Of Their Outstanding Contribution To GPCR Drug Discovery 1/27/2015 11:45:42 AM
Heptares Technology Enables Breakthrough In Drug Discovery Collaboration With AstraZeneca PLC (AZN) 1/22/2015 10:23:02 AM
Heptares Adds Experts In Drug Discovery And Development To Its Board Of Directors 1/8/2015 9:02:15 AM
Heptares To Present At Upcoming East/West CEO Conference 1/6/2015 1:42:14 PM
Heptares Extends Global Patent Protection For GPCR-Focused Drug Discovery Platform With Grant Of Core Patents In The United States 12/15/2014 7:34:57 AM
Heptares Orphan Disease Programme Awarded Grant From The UK Biomedical Catalyst 11/20/2014 1:14:35 PM
Heptares First-In-Class Selective Muscarinic Agonists Chosen As One Of Top Neuroscience Projects To Watch 11/17/2014 11:36:36 AM
12345
//-->